Plant-Based

Solutions Database

Repurposing and retrofitting facilities for use in alternative protein manufacturing

The manufacturing capacity for rapid and cost-effective scale-up of alternative protein production is a current constraint on the growth of the industry. Repurposing and retrofitting stranded or underutilized assets such as shuttered bioethanol plants can help mitigate some of the financial hurdles and shorten the amount of time required for companies to expand production.

A group of entrepreneurs gathered around a table meeting about their business plan
Event

The Business of Alt Protein: Building high performance teams

In this Business of Alt Protein seminar, you’ll hear from Maureen McCusker, Co-Founder/CEO of Blackhawke Behavioral Science. Dr. McCusker brings her deep expertise in assembling powerful teams that propel startups and early-stage companies to success. From choosing a co-founder to crafting and filling critical roles, Dr. McCusker will cover the team fundamentals that are essential for launching and scaling.

A group of entrepreneurs gathered around a table meeting about their business plan
Event

The Business of Alt Protein: Building high performance teams

In this Business of Alt Protein seminar, you’ll hear from Maureen McCusker, Co-Founder/CEO of Blackhawke Behavioral Science. Dr. McCusker brings her deep expertise in assembling powerful teams that propel startups and early-stage companies to success. From choosing a co-founder to crafting and filling critical roles, Dr. McCusker will cover the team fundamentals that are essential for launching and scaling.

Comment Letter Funding

To the Office of Science and Technology Policy on creating an interagency research initiative on alternative proteins

GFI’s comment recommends that President Biden’s Administration form a federal interagency research initiative coordinated by the Office of Science and Technology Policy to support open-access alternative protein research and development.